A case of atypical hemolytic uremic syndrome with a transient decrease in complement factor H

被引:3
|
作者
Hahn, H [1 ]
Um, EY
Park, YS
Cheong, HI
机构
[1] Eulji Univ, Sch Med, Dept Pediat, Taejon, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Pediat, Clin Res Inst, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Dept Pediat, Ulsan 680749, South Korea
关键词
complement; 3; complement factor H; hemolytic-uremic syndrome;
D O I
10.1007/s00467-005-2108-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We report a case of sporadic atypical hemolytic uremic syndrome (HUS) with a transient decrease in complement factor H. Referred for hemolysis and azotemia without diarrhea prodrome, this 31-month-old boy showed a decreased complement 3 (C3) and complement factor H (FH) level. However, the factor H gene (HF1) mutation was missing. After the hemolysis was controlled with plasma infusion, the C3 and FH levels recovered. The patient's renal function fully recovered and remained normal, and there was no recurrence of the HUS.
引用
收藏
页码:295 / 298
页数:4
相关论文
共 50 条
  • [1] A case of atypical hemolytic uremic syndrome with a transient decrease in complement factor H
    Hyewon Hahn
    Eun Young Um
    Young Seo Park
    Hae Il Cheong
    Pediatric Nephrology, 2006, 21 : 295 - 298
  • [2] IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome
    Cugno, Massimo
    Berra, Silvia
    Depetri, Federica
    Tedeschi, Silvana
    Griffini, Samantha
    Grovetti, Elena
    Caccia, Sonia
    Cresseri, Donata
    Messa, Piergiorgio
    Testa, Sara
    Giglio, Fabio
    Peyvandi, Flora
    Ardissino, Gianluigi
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (05): : 1227 - 1235
  • [3] Complement factor H and the hemolytic uremic syndrome
    Atkinson, John P.
    Goodship, Timothy H. J.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (06): : 1245 - 1248
  • [4] Complement factor H and hemolytic uremic syndrome
    Zipfel, PF
    Skerka, C
    Caprioli, J
    Manuelian, T
    Neumann, HH
    Noris, M
    Remuzzi, G
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (03) : 461 - 468
  • [5] Efficacy of plasma therapy in atypical hemolytic uremic syndrome with complement factor H mutations
    Anne-Laure Lapeyraque
    Eric Wagner
    Véronique Phan
    Marie-José Clermont
    Aïcha Merouani
    Véronique Frémeaux-Bacchi
    Timothy H. J. Goodship
    Pierre Robitaille
    Pediatric Nephrology, 2008, 23 : 1363 - 1366
  • [6] AUTOANTIBODIES TO COMPLEMENT FACTOR H ARE AN IMPORTANT CAUSE OF ATYPICAL HEMOLYTIC UREMIC SYNDROME (HUS)
    Sethi, S. K.
    Dragon-Durey, M-A
    Dinda, A.
    Hari, P.
    Bagga, A.
    PEDIATRIC NEPHROLOGY, 2009, 24 (03) : 650 - 650
  • [7] Efficacy of plasma therapy in atypical hemolytic uremic syndrome with complement factor H mutations
    Lapeyraque, Anne-Laure
    Wagner, Eric
    Phan, Veronique
    Clermont, Marie-Jose
    Merouani, Aicha
    Fremeaux-Bacchi, Veronique
    Goodship, Timothy H. J.
    Robitaille, Pierre
    PEDIATRIC NEPHROLOGY, 2008, 23 (08) : 1363 - 1366
  • [8] DISCONTINUOUS ECULIZUMAB THERAPY IN AN ATYPICAL HEMOLYTIC UREMIC SYNDROME WITH COMPLEMENT FACTOR H MUTATION
    Tenenbaum, Julie
    Ichay, Lydia
    Fila, Marc
    Fremeauxbacchi, Veronique
    Morin, Denis
    PEDIATRIC NEPHROLOGY, 2017, 32 (09) : 1690 - 1690
  • [9] Atypical hemolytic uremic syndrome: an unsolved case of complement dysregulation
    Waters, A.
    Trautmann, A.
    Zipfel, P.
    Harvey, E.
    Licht, Ch.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1595 - 1595
  • [10] Mutations in complement factor B are associated with atypical hemolytic uremic syndrome
    de Jorge, Elena Goicoechea
    Harris, Claire L.
    Esparza-Gordillo, Jorge
    Carreras, Luis
    Arranz, Elena Aller
    Garrido, Cynthia Abarrategui
    López-Trascasa, Margarita
    Sánchez-Corral, Pilar
    Morgan, B. Paul
    de Córdoba, Santiago Rodríguez
    MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 178 - 179